(Stroke. 2000;31:1299.)
© 2000 American Heart Association, Inc.
Original Contributions |
From the Department of Physiology, School of Medicine (Y.K.), and Department of Epidemiology, Medical Research Institute (Y.K., A.H.C., T.Y., H.T.), Tokyo Medical and Dental University, Tokyo, Japan; Department of Public Health, Osaka City University Medical School, Osaka, Japan (C.D.); and Hokuetsu Hospital, Shibata City, Niigata, Japan (H.S.).
Correspondence to Yoshihiro Kokubo, MD, Department of Epidemiology, Medical Research Institute, Tokyo Medical and Dental University, 2-3-10 Kanda-Surugadai, Chiyoda-ku, Tokyo, 101-0062, Japan. E-mail kokubo.epi{at}mri.tmd.ac.jp
Background and PurposeThe association between apolipoprotein E (apoE) polymorphisms and stroke has been controversial. These controversies may be due to inaccurate classification of stroke and differences in age ranges. We investigated the association between apoE genotypes and stroke subtypes (confirmed by CT or MRI findings) by case-control study in a Japanese rural population.
MethodsFirst-ever-stroke patients (n=322; cerebral infarction, n=201, intracerebral hemorrhage, n=84, and subarachnoid hemorrhage, n=37) aged 40 to 89 years were recruited from Hokuetsu Hospital, Japan. Healthy controls (n=1126) were selected from the general population in the same area. ApoE genotypes were determined by restriction fragment-length polymorphism analysis.
ResultsCompared with apoE
3/
3 subjects,
2 carriers had
a 2-fold risk of cerebral infarction (OR 1.9, 95% CI 1.1 to 3.2).
Among cerebral infarction patients,
2 carriers had increased risks
of cortical infarction (OR 2.4, 95% CI 1.3 to 4.6) (an anatomic
subtype) and atherothrombosis (OR 3.9, 95% CI 1.7 to 9.0) and
cardioembolism (OR 4.9, 95% CI 1.6 to 14.4) but not
lacunar infarction (clinical subtypes). ApoE
4 carriers had a
2.5-fold risk of subarachnoid hemorrhage (OR 2.5, 95%
CI 1.1 to 5.4). ApoE
2/
2 subjects had an increased risk of
intracerebral hemorrhage (OR 4.4, 95% CI 1.0
to 19.7). ApoE
3/
4 subjects showed
2-fold increased risk of
atherothrombosis (OR 2.1, 95% CI 1.0 to 4.1) and
intracerebral hemorrhage (OR 1.8, 95% CI 1.0
to 3.3). The association between
2 and stroke was accentuated in
subjects aged 70 years or older but not in those aged 40 to 69
years.
ConclusionsOur study suggests that apoE
2 is a risk factor
for atherothrombosis, cardioembolism, and
intracerebral hemorrhage, whereas
4 is a
risk factor for atherothrombosis, intracerebral
hemorrhage, and subarachnoid hemorrhage. The
occurrence of stroke may be affected by interaction between age and
apoE gene polymorphisms.
Key Words: apolipoproteins genetics stroke classification Japan
This article has been cited by other articles:
![]() |
S. Debette and S. Seshadri Genetics of Atherothrombotic and Lacunar Stroke Circ Cardiovasc Genet, April 1, 2009; 2(2): 191 - 198. [Full Text] [PDF] |
||||
![]() |
C. Tzourio, H. Arima, S. Harrap, C. Anderson, O. Godin, M. Woodward, B. Neal, M-G Bousser, J. Chalmers, F. Cambien, et al. APOE genotype, ethnicity, and the risk of cerebral hemorrhage Neurology, April 15, 2008; 70(16): 1322 - 1328. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lemmens, A. Gorner, M. Schrooten, and V. Thijs Association of Apolipoprotein E {epsilon}2 With White Matter Disease but Not With Microbleeds Stroke, April 1, 2007; 38(4): 1185 - 1188. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Mineharu, K. Inoue, S. Inoue, S. Yamada, K. Nozaki, K. Takenaka, N. Hashimoto, and A. Koizumi Association Analysis of Common Variants of ELN, NOS2A, APOE and ACE2 to Intracranial Aneurysm Stroke, May 1, 2006; 37(5): 1189 - 1194. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Lane and M. R. Farlow Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease J. Lipid Res., May 1, 2005; 46(5): 949 - 968. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pezzini, M. Grassi, E. D. Zotto, S. Archetti, R. Spezi, V. Vergani, D. Assanelli, L. Caimi, and A. Padovani Cumulative Effect of Predisposing Genotypes and Their Interaction With Modifiable Factors on the Risk of Ischemic Stroke in Young Adults Stroke, March 1, 2005; 36(3): 533 - 539. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yamada, M. Utsunomiya, K. Inoue, K. Nozaki, S. Inoue, K. Takenaka, N. Hashimoto, and A. Koizumi Genome-Wide Scan for Japanese Familial Intracranial Aneurysms: Linkage to Several Chromosomal Regions Circulation, December 14, 2004; 110(24): 3727 - 3733. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Leys and F. Pasquier Editorial Comment--Not All Hypertensive Subjects Have Similar Risks for White Matter Lesions: Influence of Genetic Factors Stroke, May 1, 2004; 35(5): 1061 - 1062. [Full Text] [PDF] |
||||
![]() |
A. Pezzini, M. Grassi, E. Del Zotto, E. Bazzoli, S. Archetti, D. Assanelli, N. M. Akkawi, A. Albertini, and A. Padovani Synergistic Effect of Apolipoprotein E Polymorphisms and Cigarette Smoking on Risk of Ischemic Stroke in Young Adults Stroke, February 1, 2004; 35(2): 438 - 442. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Niino, S Kikuchi, T Fukazawa, I Yabe, and K Tashiro Polymorphisms of apolipoprotein E and Japanese patients with multiple sclerosis Multiple Sclerosis, August 1, 2003; 9(4): 382 - 386. [Abstract] [PDF] |
||||
![]() |
J. F. Meschia Addressing the Heterogeneity of the Ischemic Stroke Phenotype in Human Genetics Research Stroke, December 1, 2002; 33(12): 2770 - 2774. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H.S. Leung, W.S. Poon, L.M. Yu, G. K.C. Wong, and H.K. Ng Apolipoprotein E Genotype and Outcome in Aneurysmal Subarachnoid Hemorrhage Stroke, February 1, 2002; 33(2): 548 - 552. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.J.C. Slooter, M. L. Bots, L. M. Havekes, A. I. del Sol, M. Cruts, D. E. Grobbee, A. Hofman, C. Van Broeckhoven, J.C.M. Witteman, and C. M. van Duijn Apolipoprotein E and Carotid Artery Atherosclerosis: The Rotterdam Study Stroke, September 1, 2001; 32(9): 1947 - 1952. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |